Skip to main content

Bsure Medical

Bsure Medical was founded in 2020, and has a strategic alliance with the multinational company FAGRON, Bsure's industrial partner and investor.

Bsure operates in the biotechnology sector and its first product is a genetic kit for the prediction of severe adverse reactions to subcutaneous implants (Dermal Fillers).

Founders on the part of the VHIR

Simo Schwartz

Dr. Simo Schwartz

Vall d’Hebron University Hospital
Jaume Alijotas

Dr. Jaume Alijotas

Head of the Systemic Diseases research group